ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 23 filers reported holding ZOSANO PHARMA CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $423,000 | -34.6% | 900,316 | 0.0% | 0.00% | – |
| Q3 2021 | $647,000 | -23.2% | 900,316 | +1.5% | 0.00% | – |
| Q2 2021 | $842,000 | -16.3% | 887,153 | +9.3% | 0.00% | – |
| Q1 2021 | $1,006,000 | +224.5% | 811,854 | +37.6% | 0.00% | – |
| Q4 2020 | $310,000 | -47.2% | 590,007 | +62.6% | 0.00% | – |
| Q3 2020 | $587,000 | +97.0% | 362,753 | +4.0% | 0.00% | – |
| Q2 2020 | $298,000 | +373.0% | 348,832 | +210.7% | 0.00% | – |
| Q1 2020 | $63,000 | -81.5% | 112,279 | -50.0% | 0.00% | – |
| Q4 2019 | $340,000 | +94.3% | 224,558 | +100.0% | 0.00% | – |
| Q3 2019 | $175,000 | -52.3% | 112,279 | 0.0% | 0.00% | – |
| Q2 2019 | $367,000 | -5.9% | 112,279 | +37.2% | 0.00% | – |
| Q1 2019 | $390,000 | +12.7% | 81,829 | -50.0% | 0.00% | – |
| Q4 2018 | $346,000 | +3.6% | 163,658 | +100.0% | 0.00% | – |
| Q3 2018 | $334,000 | +7.4% | 81,829 | +7.2% | 0.00% | – |
| Q2 2018 | $311,000 | – | 76,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,600,000 | $7,632,000 | 5.81% |
| Telemetry Investments, L.L.C. | 242,826 | $1,158,000 | 0.59% |
| MYDA Advisors LLC | 72,000 | $343,000 | 0.17% |
| Highlander Capital Management, LLC | 10,000 | $48,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $4,770,000 | 0.01% |
| Hartford Financial Management Inc. | 2,000 | $10,000 | 0.00% |
| GABELLI FUNDS LLC | 21,297 | $102,000 | 0.00% |
| IFP Advisors, Inc | 1,248 | $6,000 | 0.00% |
| NORTHERN TRUST CORP | 16,252 | $78,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |